Genistein exerts multiple suppressive effects on human breast carcinoma cells

Cancer Research

Volumn 58, Issue 21, 1998, Pages 4851-4857

  Shao, Zhi Ming ^a,b   Wu, Jiong ^a   Shen, Zhen Zhou ^a   Barsky, Sanford H ^b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; GELATINASE B; GENISTEIN; PROTEIN P21; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER PREVENTION; CARCINOMA CELL; CELL CYCLE G2 PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; METAPHASE; MITOSIS INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; COLLAGENASES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENISTEIN; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELLS, CULTURED;

EID: 0032212387     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J Clin., 65: 5-27, 1996.
2. Messina, M. J., Persky, V., Setchell, K. D. R., and Barnes, S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer, 21: 115-131, 1994.
3. Caragay, A. B. Cancer-preventive foods and ingredients. Food Technol., 46: 65-68, 1992.
4. Barnes, S., Grubbes, C., Setchell, K. D. R., and Carison, J. Soybeans inhibit mammary tumors in models of breast cancer. In: M. W. Pariza, H-U. Aeschbacher, J. S. Felton, and S. Sato (eds.), Mutagens and Carcinogens in the diet, pp. 239-253. New York: Wiley-Liss, 1990.
5. Messina, M., and Barnes, S. Workshop report from the division of Cancer Etiology, National Cancer Institute, NIH. The role of soy in reducing the risk of certain cancers. J. Natl. Cancer Inst., 83: 541-546, 1991.
6. Barnes, S., and Peterson, T. G. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc. Soc. Exp. Biol. Med., 208: 103-108, 1995.
7. Peterson, G. Evaluation of the biochemical targets of genistein in tumor cells. J. Nutr., 125 (Suppl.): 784s-789s, 1995.
8. Constantinou, A., and Huberman, E. Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc. Soc. Exp. Biol. Med., 125: 109-115, 1995.
9. Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G., Hase, T., Montesano, R., and Schweigerer, L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA, 90: 2690-2694, 1993.
10. Fotsis, T., Pepper, M. S., Aktas, E., Breit, S., Rasku, S., Adlercreutz, H., Wahala, K., Montesano, R., and Schweigerer, L. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res., 57: 2916-2921, 1997.
11. 2/M arrest and apoptosis. J. Cell. Biochem., 69: 44-54, 1998.
12. Shao, Z-M., Sheikh, M. S., Rishi, A. K., Dawson, M., Li, X. S., Wilber, J. F., Feng, P., and Fontana, J. A. Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation. Exp. Cell Res., 218: 1-8, 1995.
13. Feinberg, A. P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132: 6-13, 1983.
14. Gum, R., Lengyel, E., Juarez, J., Chen, J. H., Sato, H., Seiki, M., and Boyd, D. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem., 271: 10672-10680, 1996.
15. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene, 11: 493-504, 1995.
16. DeClerck, Y. A. Purification and characterization of a collagenase inhibitor produced by bovine vascular smooth muscle cells. Arch. Biochem. Biophys., 265: 28-37, 1988.
17. Herron, G. S., Banda, M. J., Clark, E. J., Gavrilovic, J., and Werb, Z. Secretion of metalloproteinases by stimulated capillary endothelial cells; expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J. Biol. Chem., 261: 2814-2818, 1986.
18. Hanspal, J. S., Bushell, G. R., and Ghosh, P. Detection of proteinase inhibitors using substrate-containing sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal. Biochem., 132: 288-293, 1983.
19. Albini, A., Iwamoto, K., Kleinman, H. K., Martin, G. S., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239-3245, 1987.
20. Sternlicht, M. D., Kedeshian, P., Shao, Z-M., Safarians, S., and Barsky, S. H. The human myoepithelial cell is a natural tumor suppressor. Clin. Cancer Res., 3: 1949-1958, 1997.
21. Antibanez, J. F., Navarro, A., and Martinez, J. Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines. Anticancer Res., 17: 1199-1204, 1997.
22. Traganos, F., Ardelt, B., Halko, N., Bruno, S., and Darzynkiewicz, Z. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemia MOLT-4 and HL-60 cells. Cancer Res., 52: 6200-6208, 1992.
23. Sato, H., and Seiki, M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene, 8: 395-405, 1993.
24. Sledge, G. W., Jr., Qulali, M., Goulet, R., Bone, E. A., and Fife, R. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J. Natl. Cancer Inst., 87: 1546-1550, 1995.
25. Huhtala, P., Tuuttila, A., Chow, L. T., Lohi, J., Keski-Oja, J., and Tryggvason, K. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J. Biol. Chem., 266: 16485-16490, 1990.
26. Lin, A., Smeal, T., Binetruy, B., Deng, T., Chambard, J. C., and Karin, M. Control of AP-1 activity by signal transduction cascades. Adv. Second Messenger Phosphoproteins, 28: 255-260, 1990.
27. Chiu, R., Boyle, W. J., Meek, J., Smeal, T., Hunter, T., and Karin, M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell, 54: 41-52, 1988.
28. Cohen, D. R., Ferreira, P. C., Gentz, R., Franza, B. R., Jr., and Curran, T. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes. Genes Dev., 3: 173-184, 1989.
29. Halazonetis, T. D., Georgopoulos, K., Greenberg, M. E., and Leder, P. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell, 55: 917-924, 1988.
30. Angel, P., and Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072: 129-157, 1990.
31. Barnes, S. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res. Treat., 46: 169-179, 1997.
32. Pereira, M. A., Barnes, L. H., Rassman, V. L., Kelloff, G. V., and Steele, V. E. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis (Lond.), 15: 1049-1054, 1994.
33. Lamartiniere, C. A., Moore, J. B., Brown, N. M., Thompson, R., Hardin, M. J., and Barnes, S. Genistein suppresses mammary cancer in rats. Carcinogenesis (Lond.), 16: 2833-2840, 1995.
34. Lamartiniere, C. A., Murrill, W. B., Manzolillo, P. A., Zhang, J. X., Barnes, S., Zhang, X., Wei, H., and Brown, N. M. Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats. Proc. Soc. Exp. Biol. Med., 217: 358-364, 1998.
35. Record, I. R., Broadbent, J. L., King, R. A., Dreosti, I. E., Head, R. J., and Tonkin, A. L. Genistein inhibits growth of B16 melanoma cells in vivo and in vitro and promotes differentiation in vitro. Int. J. Cancer, 72: 860-864, 1997.
36. Zhou, Y., and Lee, A. S. Mechanism for the suppression of the mammalian stress response by genistein, an anticancer phytoestrogen from soy. J. Natl. Cancer Inst., 90: 381-388, 1998.
37. Pepper, M. S., and Montesano, R. Proteolytic balance and capillary morphogenesis. Cell Differ. Dev., 32: 319-328, 1990.
38. Gastl, G., Hermann, T., Steurer, M., Zmija, J., Gunsilius, E., Unger, C., and Kraft, A. Angiogenesis as a target for tumor treatment. Oncology, 54: 177-184, 1997.
39. Pluda, J. M. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. Semin. Oncol., 24: 203-218, 1997.
40. Relf, M., LeJeune, S., Scott, P. A., Fox, S., Smith, K., Leek, R., Moghaddam, A., Whitehouse, R., Bicknell, R., and Harris, A. L. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placental growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res., 57: 963-969, 1997.